Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

Cholangiocarcinoma is notoriously difficult to diagnose, and the mortality rate is high due to late clinical presentation. CpG island promoter methylation is frequently seen in cancer development. In the present study, we aimed at identifying novel epigenetic biomarkers with the potential to improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Andresen, Kim, Boberg, Kirsten Muri, Vedeld, Hege Marie, Honne, Hilde, Hektoen, Merete, Wadsworth, Chrisopher A., Clausen, Ole Petter, Karlsen, Tom Hemming, Foss, Aksel, Mathisen, Øystein, Schrumpf, Erik, Lothe, Ragnhild A., Lind, Guro E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499326/
https://www.ncbi.nlm.nih.gov/pubmed/22983262
http://dx.doi.org/10.4161/epi.22191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499326/
https://www.ncbi.nlm.nih.gov/pubmed/22983262
http://dx.doi.org/10.4161/epi.22191

Ejemplares similares